| Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial G Pelletier, M Ducreux, F Gay, M Luboinski, H Hagège, D Thong, ... Journal of hepatology 29 (1), 129-134, 1998 | 521 | 1998 |
| Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study H Sokol, C Landman, P Seksik, L Berard, M Montil, I Nion-Larmurier, ... Microbiome 8, 1-14, 2020 | 304 | 2020 |
| Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study A Bourrier, F Carrat, JF Colombel, AM Bouvier, V Abitbol, P Marteau, ... Alimentary pharmacology & therapeutics 43 (2), 252-261, 2016 | 148 | 2016 |
| Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study S Nahon, H Hagège, JP Latrive, I Rosa, B Nalet, B Bour, R Faroux, ... Endoscopy 44 (11), 998-1008, 2012 | 132 | 2012 |
| High risk of anal and rectal cancer in patients with anal and/or perianal Crohn’s disease L Beaugerie, F Carrat, S Nahon, JD Zeitoun, JM Sabaté, L Peyrin-Biroulet, ... Clinical Gastroenterology and Hepatology 16 (6), 892-899. e2, 2018 | 117 | 2018 |
| Randomised clinical trial: once‐vs. twice‐daily prolonged‐release mesalazine for active ulcerative colitis B Flourié, H Hagège, G Tucat, D Maetz, X Hébuterne, JP Kuyvenhoven, ... Alimentary pharmacology & therapeutics 37 (8), 767-775, 2013 | 101 | 2013 |
| Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study S Danese, JF Colombel, M Lukas, JP Gisbert, G d'Haens, B Hayee, ... The lancet Gastroenterology & hepatology 7 (2), 118-127, 2022 | 84 | 2022 |
| Asymptomatic bacterascites: is it spontaneous bacterial peritonitis? G Pelletier, G Lesur, O Ink, H Hagege, P Attali, C Buffet, JP Etienne Hepatology 14 (1), 112-115, 1991 | 82 | 1991 |
| Association of juxtapapillary diverticula with choledocholithiasis but not with cholecystolithiasis H Hagege, A Berson, G Pelletier, J Fritsch, A Choury, C Liguory, ... Endoscopy 24 (04), 248-251, 1992 | 81 | 1992 |
| Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study CE Costentin, A Mourad, P Lahmek, X Causse, A Pariente, H Hagège, ... Cancer 124 (9), 1964-1972, 2018 | 73 | 2018 |
| Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis P Chrétien, M Chousterman, I Abd Alsamad, V Ozenne, I Rosa, C Barrault, ... Journal of Autoimmunity 32 (3-4), 201-205, 2009 | 71 | 2009 |
| A low-volume polyethylene glycol plus ascorbate solution for bowel cleansing prior to colonoscopy: the NORMO randomised clinical trial T Ponchon, C Boustière, D Heresbach, H Hagege, AL Tarrerias, ... Digestive and Liver Disease 45 (10), 820-826, 2013 | 70 | 2013 |
| Results of a national survey on quality of life in inflammatory bowel diseases AC Lesage, H Hagège, G Tucat, JP Gendre Clinics and Research in Hepatology and Gastroenterology 35 (2), 117-124, 2011 | 66 | 2011 |
| Hepatitis C associated with Guillain‐Barré syndrome F Lacaille, H Zylberberg, H Hagège, B Roualdès, C Meyrignac, ... Liver 18 (1), 49-51, 1998 | 66 | 1998 |
| Long-term portosystemic shunt patency as a determinant of outcome in Budd–Chiari syndrome JB Bachet, B Condat, H Hagège, A Plessier, Y Consigny, J Belghiti, ... Journal of hepatology 46 (1), 60-68, 2007 | 65 | 2007 |
| Favorable prognosis of upper-gastrointestinal bleeding in 1041 older patients: results of a prospective multicenter study S Nahon, O Nouel, H Hagège, P Cassan, A Pariente, R Combes, ... Clinical Gastroenterology and Hepatology 6 (8), 886-892, 2008 | 56 | 2008 |
| The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease F Carrat, P Seksik, JF Colombel, L Peyrin‐Biroulet, L Beaugerie, ... Alimentary pharmacology & therapeutics 45 (4), 533-541, 2017 | 50 | 2017 |
| A national French survey on the use of growth factors as adjuvant treatment of chronic hepatitis C T Thévenot, JF Cadranel, V Di Martino, A Pariente, X Causse, C Renou, ... Hepatology 45 (2), 377-383, 2007 | 50 | 2007 |
| Cystic dystrophy of the duodenal wall associated with chronic alcoholic pancreatitis: clinical features, diagnostic procedures and therapeutic management in a retrospective … V Jouannaud, P Coutarel, H Tossou, J Butel, RL Vitte, F SkiNaZi, ... Gastroentérologie clinique et biologique 30 (4), 580-586, 2006 | 46 | 2006 |
| Pharmacokinetics of metoclopramide in patients with liver cirrhosis. E Magueur, H Hagege, P Attali, E Singlas, JP Etienne, AM Taburet British journal of clinical pharmacology 31 (2), 185-187, 1991 | 41 | 1991 |
